These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 580518)

  • 1. Growth-hormone dependence of non-suppressible insulin-like activity (NSILA) and of NSILA-carrier protein in rats.
    Kaufmann U; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):716-27. PubMed ID: 580518
    [No Abstract]   [Full Text] [Related]  

  • 2. The influence of hypophysectomy on NSILA concentrations in the dog: evidence for partially pituitary-independent regulation.
    Eigenmann JE; Becker M; Kammermann B; Zapf J; Leemann W; Froesch ER
    Acta Endocrinol (Copenh); 1977 Nov; 86(3):498-503. PubMed ID: 579020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-suppressible insulin-like activity during acute metabolic and endocrine changes in dogs.
    Eigenmann JE; Francke-Mäder M; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1977 Jul; 85(3):571-8. PubMed ID: 577341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy.
    Eigenmann JE; Becker M; Kammermann B; Leemann W; Heimann R; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1977 Aug; 85(4):818-22. PubMed ID: 578061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of different extraction procedures on two different molecular weight species of serum NSILA and on the carrier protein of small molecular weight NSILA (NSILA-S).
    Kaufmann U; Zapf J; Froesch ER
    Acta Endocrinol (Copenh); 1979 Apr; 90(4):637-47. PubMed ID: 34963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsuppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels.
    Schalch DS; Heinrich UE; Koch JG; Johnson CJ; Schlueter RJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):664-71. PubMed ID: 755052
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of the acid-ethanol soluble component of non-suppressible insulin-like activity in untreated and treated streptozotocin-diabetic rats.
    Franklin RC; Rennie GC; Cameron DP
    J Endocrinol; 1979 Jun; 81(3):331-7. PubMed ID: 469463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating NSILA-s in man: Preliminary studies of stimuli in vivo and of binding to plasma components.
    Megyesi K; Kahn CR; Roth J; Gorden P
    J Clin Endocrinol Metab; 1975 Sep; 41(3):475-84. PubMed ID: 169287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in NSILA-S in response to somatotropin administration and hypophysectomy.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1978 Jul; 47(1):91-6. PubMed ID: 263296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of serum nonsuppressible insulin-like activity (NSILA) in compensatory renal growth.
    Poffenbarger PL; Prince MJ
    Growth; 1976 Mar; 40(1):83-97. PubMed ID: 177337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart.
    Meuli C; Zapf J; Froesch ER
    Diabetologia; 1978 Apr; 14(4):255-9. PubMed ID: 640301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-suppressible insulin-like activity in Laron's syndrome.
    Kastrup KW; Zapf J
    Acta Endocrinol (Copenh); 1979 Mar; 90(3):414-20. PubMed ID: 425784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum.
    Cornell HJ; Herington AC
    Int J Biochem; 1983; 15(4):553-8. PubMed ID: 6852354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The serum half-life of somatomedin activity: evidence for growth hormone dependence.
    Cohen KL; Nissley SP
    Acta Endocrinol (Copenh); 1976 Oct; 83(2):243-58. PubMed ID: 989660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific binding of a somatomedin-like polypeptide in rat serum depends on growth hormone.
    Moses AC; Nessley SP; Cohen KL; Rechler MM
    Nature; 1976 Sep; 263(5573):137-40. PubMed ID: 967246
    [No Abstract]   [Full Text] [Related]  

  • 20. Ontogeny of pituitary regulation of growth in the developing rat: comparison of effects of hypophysectomy and hormone replacement on somatic and organ growth, serum insulin-like growth factor-I (IGF-I) and IGF-II levels, and IGF-binding protein levels in the neonatal and juvenile rat.
    Glasscock GF; Gin KK; Kim JD; Hintz RL; Rosenfeld RG
    Endocrinology; 1991 Feb; 128(2):1036-47. PubMed ID: 1703478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.